SCHEMBL11155800

SCHEMBL11155800

CC1=C(C(=O)O)N2C(=O)C(NC(=O)/C(=N\OCC(=O)O)c3cscn3)[C@@H]2SC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.59
▸ APAF1 O14727 2/20 0.59
▸ LMNA P02545 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ APEX1 P27695 1/20 0.59
▸ PLCG1 P19174 1/20 0.59
▸ ABCC2 Q92887 1/20 0.59
▸ SIRT5 Q9NXA8 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ PSMD14 O00487 1/20 0.58
▸ MMP2 P08253 1/20 0.58
▸ NR1I2 O75469 4/20 0.53
▸ HTR2C P28335 1/20 0.53
▸ PPARG P37231 2/20 0.51
▸ SLC22A6 Q4U2R8 2/20 0.51
▸ SLC22A8 Q8TCC7 2/20 0.51
▸ SLC22A11 Q9NSA0 2/20 0.51
▸ ALB P02768 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ CACNA1B Q00975 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10674228 1.00 TDP1 (0.59) TDP1APAF1LMNATSHRAPEX1
SCHEMBL10674221 1.00 TDP1 (0.59) TDP1APAF1LMNATSHRAPEX1
SCHEMBL10671700 0.91 TDP1 (0.49) TDP1APAF1LMNATSHRAPEX1
SCHEMBL10671707 0.91 TDP1 (0.49) TDP1APAF1LMNATSHRAPEX1
SCHEMBL10670048 0.90 TDP1 (0.57) TDP1APAF1LMNATSHRAPEX1
SCHEMBL10924742 0.90 TDP1 (0.50) TDP1APAF1LMNATSHRAPEX1
SCHEMBL10670059 0.90 TDP1 (0.57) TDP1APAF1LMNATSHRAPEX1
SCHEMBL10673752 0.90 TDP1 (0.59) TDP1APAF1LMNATSHRAPEX1
SCHEMBL10673746 0.90 TDP1 (0.59) TDP1APAF1LMNATSHRAPEX1
SCHEMBL29569065 0.90 NR1I2 (0.59) TDP1LMNATSHRAPEX1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0071891-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-02-16 — — EP disclosed
Send feedback